Recent share performance and business overview

Morningstar (MORN) has drawn fresh investor attention after the stock fell about 5% over the past month but gained roughly 6% over the past 3 months, with a 1 day move of about 2%.

The company, headquartered in Chicago, provides independent investment insights and tools across five segments: the Morningstar Direct Platform, PitchBook, Morningstar Credit, Morningstar Wealth, and Morningstar Retirement, serving investors and advisors worldwide.

At a share price of $170.04, Morningstar’s recent 1 day share price return of 2.40% contrasts with a 30 day share price return down 5.25% and a 1 year total shareholder return down 44.57%, suggesting pressure has been building rather than momentum.

If this kind of move has you thinking about where else capital could work harder, it may be worth scanning for opportunities among 19 top founder-led companies

With shares down 44.6% over the past year, even as annual revenue and net income growth sit near 7.1% and 9.8%, the key question is simple: is Morningstar now undervalued, or is the market already pricing in future growth?

Preferred P/E of 16.1x: Is it justified?

Morningstar trades on a P/E of 16.1x at a last close of $170.04, which sits below both the wider US market and the Capital Markets industry average, yet still slightly above its own estimated fair P/E.

The P/E multiple compares the current share price to earnings per share and is a common way investors frame what they are paying for each dollar of profit in information and analytics companies like Morningstar.

Here, the stock is flagged as good value on a P/E basis against several benchmarks: its 16.1x multiple is lower than the peer average of 25x, below the US Capital Markets industry average of 41.2x, and below the broader US market at 18.7x. At the same time, the SWS fair ratio work suggests a P/E of 14.1x could be more in line with the company’s earnings profile. This implies some room for the market multiple to compress toward that level if sentiment cools.

Putting it together, earnings growth near 9.8% a year that is slower than both the market and industry, slightly softer margins compared to last year, and an estimated future cash flow value of $132.46 all feed into the question of whether investors are comfortable paying above the DCF estimate but below peer multiples for this earnings stream.

Result: Price-to-earnings of 16.1x (ABOUT RIGHT)

However, there are clear risks, including pressure from slower earnings growth than peers and any cooling demand in key platforms such as PitchBook or Morningstar Direct.

Another view: DCF points to a different price

While the P/E of 16.1x makes Morningstar look reasonably priced against peers, the SWS DCF model comes out more cautious. With the stock at $170.04 and an estimated future cash flow value of $132.46, the shares screen as overvalued on this lens. This raises the question of which signal to trust.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Morningstar for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals from P/E, DCF, risks and rewards, the story is not one sided. Review the data yourself and weigh both sides with 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If this analysis has sharpened your thinking, do not stop here. The best opportunities often show up when you compare a few strong candidates side by side.

• Target potential mispricings by scanning 50 high quality undervalued stocks that combine compelling fundamentals with a price tag that still looks reasonable.
• Strengthen your income stream by reviewing 12 dividend fortresses that aim to pair higher yields with resilient business models.
• Reduce portfolio stress by shortlisting 66 resilient stocks with low risk scores that score well on financial health and volatility.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.